Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.
about
Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cellsEzrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.Wnt3a induces exosome secretion from primary cultured rat microglia.Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins.The genomic and proteomic content of cancer cell-derived exosomesHIV Assembly and Budding: Ca(2+) Signaling and Non-ESCRT Proteins Set the Stage.Drosophila sticky/citron kinase is a regulator of cell-cycle progression, genetically interacts with Argonaute 1 and modulates epigenetic gene silencing.Roles of rho GTPases in intracellular transport and cellular transformation.Itinerant exosomes: emerging roles in cell and tissue polarityThe comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART eraSignaling pathways in exosomes biogenesis, secretion and fate.Exosomes: immune properties and potential clinical implementations.Urinary exosomes and proteomics.Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders.MicroRNA transport: a new way in cell communication.Rho'ing in and out of cells: viral interactions with Rho GTPase signalingCurrent knowledge on exosome biogenesis and release.NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells.Hrs inhibits citron kinase-mediated HIV-1 budding via its FYVE domain.Citron kinase enhances ubiquitination of HIV-1 Gag protein and intracellular HIV-1 budding.Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity.
P2860
Q33422993-7112AD12-7E35-4598-9DF2-9BE77320DE5EQ33744093-367546EE-D56B-449C-BF61-FEE9D9F48E57Q34485686-A78AAA89-57C8-4CA9-817E-C983ABD2F906Q34675246-0EA279BC-7591-4AAF-8923-F2C2F5F741CAQ35971555-20311DB8-A13A-4635-8210-EEC0D054250EQ36063560-0695AB5C-E84E-4816-9DBA-015F79C7076CQ36515859-B3B9B5EB-F552-450B-B2B7-D3724FA5A2B7Q36820419-7FA9DF04-1D47-4884-A0BC-E6C613D44551Q37125856-475F41C6-5A6B-4D0C-970B-4490FF520162Q37193610-E47B220D-96A8-43E7-B730-087E835ED6A7Q37508157-40D58899-D9FB-4814-96BE-7D55F1EDAB42Q37822692-AA3F70DA-98CD-4A0B-9588-A3D002E101CDQ37872261-BCF2118B-54FF-4A9B-A542-26FA5C0BE140Q38011636-2FBA281C-BE9A-4AD9-BA30-9DFCC8389D91Q38086512-4AA989C0-2647-4F98-8B37-086B672AA020Q38201237-2AE38307-9E2D-49ED-9CDF-4A05294C8FC1Q39451543-CFDE4586-1329-49C1-ADFA-914770340084Q39452623-953E0032-1ABB-4419-8E22-BE94CD6C39A4Q39718620-C43FCBFA-7448-4B99-BA4A-0ADB57C636A2Q40285743-C2CC8E1C-1AD0-4E75-96B8-5DEB39985D0DQ40684135-58C91E0F-566B-46C2-9BAE-50BB3CCFAE9AQ41712949-B0C1EDF1-2A70-45B3-9BB7-0DE101033434Q54966511-2BC24C3B-9AB5-4B71-809C-0673A58C76B9
P2860
Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@ast
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@en
type
label
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@ast
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@en
prefLabel
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@ast
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@en
P2093
P2860
P1433
P1476
Citron kinase, a RhoA effector ...... tion by modulating exocytosis.
@en
P2093
Andrew Elms
Channing J Der
Derek A Holmes
Patricia A Solski
Rebecca J Loomis
P2860
P304
P356
10.1111/J.1600-0854.2006.00503.X
P577
2006-12-01T00:00:00Z